Daejeon, South Korea

Soon Min Chung

This inventor holds 1 USPTO granted patent. Top assignee: Lg Life Sciences, Limited. Active years: 2013.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Soon Min Chung

Introduction

Soon Min Chung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of contrast agents for medical imaging. His innovative work has led to the creation of a novel process that enhances the purity and yield of iopromide, a crucial compound used in X-ray imaging.

Latest Patents

Soon Min Chung holds 1 patent for his invention titled "Process for preparation of iopromide." This patent describes a unique method for synthesizing iopromide, which involves the use of specific intermediates to eliminate by-products during the preparation process. This advancement allows for the production of high-purity iopromide in greater yields, thereby improving its effectiveness as a contrast agent.

Career Highlights

Chung is currently associated with LG Life Sciences, Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in chemical processes and dedication to research have positioned him as a valuable asset in the field of medical imaging.

Collaborations

Throughout his career, Soon Min Chung has collaborated with esteemed colleagues such as Chang Ki Kim and Bok Tae Kim. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Soon Min Chung's contributions to the development of iopromide highlight his innovative spirit and commitment to improving medical imaging technologies. His work not only enhances the quality of diagnostic procedures but also exemplifies the importance of research and collaboration in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…